Search Results - "CALMUS, Y"

Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial by Saliba, F., Duvoux, C., Gugenheim, J., Kamar, N., Dharancy, S., Salamé, E., Neau‐Cransac, M., Durand, F., Houssel‐Debry, P., Vanlemmens, C., Pageaux, G., Hardwigsen, J., Eyraud, D., Calmus, Y., Di Giambattista, F., Dumortier, J., Conti, F.

“…SIMCER was a 6‐mo, multicenter, open‐label trial. Selected de novo liver transplant recipients were randomized (week 4) to everolimus with low‐exposure…”
Get full text

Reduced‐Dose Tacrolimus with Mycophenolate Mofetil vs. Standard‐Dose Tacrolimus in Liver Transplantation: A Randomized Study by Boudjema, K., Camus, C., Saliba, F., Calmus, Y., Salamé, E., Pageaux, G., Ducerf, C., Duvoux, C., Mouchel, C., Renault, A., Compagnon, P., Lorho, R., Bellissant, E.

“…We conducted a multicenter randomized study in liver transplantation to compare standard‐dose tacrolimus to reduced‐dose tacrolimus with mycophenolate mofetil…”
Get full text

Safety and Efficacy of Raltegravir in HIV‐Infected Transplant Patients Cotreated with Immunosuppressive Drugs by Tricot, L., Teicher, E., Peytavin, G., Zucman, D., Conti, F., Calmus, Y., Barrou, B., Duvivier, C., Fontaine, C., Welker, Y., Billy, C., De Truchis, P., Delahousse, M., Vittecoq, D., Salmon‐Céron, D.

“…Solid organ transplantations (SOT) are performed successfully in selected HIV‐infected patients. However, multiple and reciprocal drug–drug interactions are…”
Get full text

Are cirrhotic patients awaiting liver transplantation protected against vaccine-preventable diseases? by Mazzola, A., Minh, M. Tran, Jauréguiberry, S., Bernard, D., Lebray, P., Chrétien, Y., Goumard, C., Calmus, Y., Conti, F.

“…Cirrhotic patients are immunocompromised and have an increased risk of infection with higher morbidity and mortality. Few data are available regarding the…”
Get full text

Aggressive hepatocellular carcinoma occurring during direct antiviral therapy by Mazzola, A, Perdigao, F, Tripon, S, Calmus, Y, Wagner, M, Conti, F

Get full text

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas by KELAIDI, C, ROLLOT, F, DREYFUS, F, PARK, S, TULLIEZ, M, CHRISTOFOROV, B, CALMUS, Y, PODEVIN, P, BOUSCARY, D, SOGNI, P, BLANCHE, P

“…A link between chronic hepatitis C virus (HCV) infection and low-grade B-cell lymphomas has been suggested by epidemiological studies. Marginal zone lymphomas…”
Get full text

Development an in Vitro Model Culture for Testing of Anti-Fibrotic Drugs using Human Precision Cut Liver Slices by Aoudjehane, L, Legrand, M, Perdigao, F, Scatton, O, Becquart, J, Housset, C, Calmus, Y, Conti, F

Get full text

Impact on Renal Function of Stepwise Withdrawal of Tacrolimus Combined with Everolimus and EC-MPS vs Standard Treatment Combining Tacrolimus and EC-MPS in De Novo Liver Transplant Recipients: Results of the Simcer Study by Conti, F, Saliba, F, Duvoux, C, Dharancy, S, Dumortier, J, Di Giambattista, F, Calmus, Y

Get full text

Regulatory T cell therapy: An option to induce operational tolerance in liver transplantation by Conti, F, Dahlqvist, G, Brisson, H, Miyara, M, Calmus, Y, Gorochov, G

“…Summary Regulatory T cells (Treg) may play an important role in operational (clinical) tolerance (OT), a stable graft function without immunosuppression in an…”
Get full text

P0689 : The hepatitis C virus contributes to the aggravation of the immunosuppressive environment by increasing the suppressive activity of natural regulatory T cells by Ouaguia, L, Morales, O, Wychowski, C, Carpentier, A, Aoudjehane, L, Dubuisson, J, Calmus, Y, deLaunoit, Y, Conti, F, Delhem, N

Get full text

Both Biochemical Hepatitis and Cholestasis at Six Months after Liver Transplantation Predict Recurrent Primary Biliary Cholangitis by Montano-Loza, A.J, Roccarina, D, Thorburn, D, Corpechot, C, Dumortier, J, Bosch, A, Giostria, E, Calmus, Y, Franceschet, I, Floreani, A, Mason, A

Get full text

Long-Term Outcome in Liver Transplantation Candidates with Portopulmonary Hypertension by Savale, L, Sattler, C, Calmus, Y, Duvoux, C, Durand, F, Conti, F, Feray, C, Francoz, C, Hervé, P, Samuel, D, Duclos-Vallée, J.C, Sitbon, O

Get full text

Are cirrhotic patients awaiting liver transplantation protected against vaccine preventable diseases? by Tran Minh, M, Mazzola, A, Pais, R, Lebray, P, Bernard, D, Goumard, C, Calmus, Y, Conti, F

Get full text

557 IL-4 AND IL-13 OVER-EXPRESSION IN SEVERE RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION by Aoudjehane, L, Briand, V, Beauverger, P, Janiak, P, Calmus, Y, Conti, F

Get full text

P1148 : Long-term administration of ursodeoxycholic acid prevents recurrence of primary biliary cirrhosis after liver transplantation by Bosch, A, Dumortier, J, Maucor Boulch, D, Conti, F, Morard, I, Rubbia-Brandt, L, Scoazec, J.-Y, Wendum, D, Terris, B, Boillot, O, Radenne, S, Chazouillères, O, Calmus, Y, Giostra, E, Corpechot, C

Get full text

Increased Expression of Regulatory Tr1 Cells in Recurrent Hepatitis C after Liver Transplantation by Carpentier, A., Conti, F., Stenard, F., Aoudjehane, L., Miroux, C., Podevin, P., Morales, O., Chouzenoux, S., Scatton, O., Groux, H., Auriault, C., Calmus, Y., Pancre, V., Delhem, N.

“…Immune response failure during HCV infection has been associated with the activity of regulatory T cells. Hepatitis C‐related cirrhosis is the main reason for…”
Get full text

Hepatitis C virus contributes to aggravation of the immunosuppressive environment by increasing the suppressive activity of natural regulatory T cells by Ouaguia, L, Moralès, O, Wychowski, C, Carpentier, A, Aoudjehane, L, Dubuisson, J, Calmus, Y, de Launoit, Y, Conti, F, Delhem, N

Get full text

APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology by Pissaia, A, Borderie, D, Bernard, D, Scatton, O, Calmus, Y, Conti, F

“…Abstract Noninvasive liver fibrosis scores are evaluated in hepatitis C virus-infected patients but are less known in liver transplant recipients. Fibrosis is…”
Get full text

Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review by Lanternier, F., Boutboul, D., Menotti, J., Chandesris, M.O., Sarfati, C., Mamzer Bruneel, M.F., Calmus, Y., Mechaï, F., Viard, J.P., Lecuit, M., Bougnoux, M.E., Lortholary, O.

“…: Microsporidiosis first came to prominence as an opportunistic infection in patients with acquired immunodeficiency syndrome. Microsporidia are now emerging…”
Get full text

Corticosteroids Do Not Reverse the Inhibitory Effect of Cyclosporine on Regulatory T-Cell Activity in Contrast to Mycophenolate Mofetil by Miroux, C, Morales, O, Ouaguia, L, Aoudjehane, L, Boleslawski, E, Pancré, V, de Launoit, Y, Calmus, Y, Conti, F, Delhem, N

“…Abstract Background Inevitable hepatitis C virus recurrence after liver transplantation, a major barrier to survival of the transplanted liver may be promoted…”
Get full text